PHILADELPHIA and Vancouver, British Columbia, Dec. 11, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” ...
BriaCell Therapeutics shares are trading lower by 40% Thursday afternoon. The company announced the pricing of a $5.5 million public offering.
BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotechnology company, Thursday announced the pricing of an underwritten public ...
BriaCell Therapeutics (BCT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Emily ...
Briacell Therapeutics Corp’s profitability metrics reveal financial health. The company currently boasts a gross margin of -16.03%. The profit margin, also known as the revenue ratio or gross profit ...
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announces that the Data Safety Monitoring Board ...
SAN ANTONIO -- The addition of palbociclib (Ibrance) to current standard-of-care therapy following induction chemotherapy ...
Short interest in BriaCell Therapeutics Corp (NASDAQ:BCTX) decreased during the last reporting period, falling from 745.07K to 534.83K. This put 1.66% of the company's publicly available shares short.
Baystreet.ca - Canada's main stock index opened lower on Thursday, hurt by mining shares, after the previous session's gains following the Bank of Canada's interest rate cut, while investors assessed ...
The notes will be senior, unsecured obligations of Nutanix. The notes will bear interest at a rate of 0.50% per year. Interest will be payable semi-annually in arrears on June 15 and December 15 of ...
Canada Post, union still at odds as strike nears 1 month Canada Post, union still at odds as strike nears 1 month Canada Post says the latest offer from the union representing its striking workers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback